Skip to content

Functional kidney MRI: developing new sequences

Functional kidney MRI: developing new sequences - NephrOx

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41651
Enrollment
15
Registered
2014-06-04
Start date
2014-10-01
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease Kidney failure

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: age 18 years or over able to give informed consent

Exclusion criteria

Exclusion criteria: - not willing to be informed about unexpected findings during the study - (possible) pregnancy or lactation - previous donor nephrectomy - known or suspected diseases or conditions that could interfere with the study - use of any prescribed medication (excl. contraceptives) and home use of NSAID*s - body mass index >30 - diagnosed hypertension or hypertension (>140/90mmHg) upon screening;For MRI scanning in general: - claustrophobia - metal implants, devices etc.: endoprosthesis, pacemaker, birth control device (IUD), neurostimulator, - - insulin pump, intra-ocular metal particles, metal heart valve, cochlear implant - previous severe allergic reaction to contrast medium (only when contrast is used, healthy subjects phase 1);For GFR measurement (applicable to healthy subjects only) - iodine allergy

Design outcomes

Primary

MeasureTime frame
Phase 1: Reproducibility of renal BOLD signal, blood flow and blood/tissue/urine fractions Phase 2: Intra individual changes in renal MRI signals (BOLD, blood flow and blood/tissue/urine fractions) and GFR and ERPF before and during reduced renal perfusion.

Secondary

MeasureTime frame
Phase 2: Change in blood pressure induced by angiotensin II

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)